1. Home
  2. CRDF vs SUNS Comparison

CRDF vs SUNS Comparison

Compare CRDF & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • SUNS
  • Stock Information
  • Founded
  • CRDF 1999
  • SUNS 2023
  • Country
  • CRDF United States
  • SUNS United States
  • Employees
  • CRDF N/A
  • SUNS N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • SUNS Real Estate Investment Trusts
  • Sector
  • CRDF Health Care
  • SUNS Real Estate
  • Exchange
  • CRDF Nasdaq
  • SUNS Nasdaq
  • Market Cap
  • CRDF 169.6M
  • SUNS 148.2M
  • IPO Year
  • CRDF N/A
  • SUNS N/A
  • Fundamental
  • Price
  • CRDF $3.21
  • SUNS $11.08
  • Analyst Decision
  • CRDF Strong Buy
  • SUNS Strong Buy
  • Analyst Count
  • CRDF 5
  • SUNS 3
  • Target Price
  • CRDF $10.50
  • SUNS $13.42
  • AVG Volume (30 Days)
  • CRDF 1.2M
  • SUNS 64.0K
  • Earning Date
  • CRDF 08-07-2025
  • SUNS 08-07-2025
  • Dividend Yield
  • CRDF N/A
  • SUNS 10.80%
  • EPS Growth
  • CRDF N/A
  • SUNS N/A
  • EPS
  • CRDF N/A
  • SUNS 1.02
  • Revenue
  • CRDF $587,000.00
  • SUNS $13,066,680.00
  • Revenue This Year
  • CRDF N/A
  • SUNS $148.89
  • Revenue Next Year
  • CRDF N/A
  • SUNS $43.47
  • P/E Ratio
  • CRDF N/A
  • SUNS $10.90
  • Revenue Growth
  • CRDF N/A
  • SUNS 1342.10
  • 52 Week Low
  • CRDF $2.01
  • SUNS $7.80
  • 52 Week High
  • CRDF $5.64
  • SUNS $15.74
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 44.28
  • SUNS N/A
  • Support Level
  • CRDF $2.96
  • SUNS N/A
  • Resistance Level
  • CRDF $3.24
  • SUNS N/A
  • Average True Range (ATR)
  • CRDF 0.28
  • SUNS 0.00
  • MACD
  • CRDF -0.10
  • SUNS 0.00
  • Stochastic Oscillator
  • CRDF 13.03
  • SUNS 0.00

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

Share on Social Networks: